Geostatistical analysis to guide treatment decisions for soil-transmitted helminthiasis control in Uganda
PLOS Neglected Tropical Diseases · 2025
DOI: 10.1371/journal.pntd.0013467 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, 2025. Verfasst von Bryan O Nyawanda und 9 weiteren Autor:innen. Beteiligte Einrichtung: Swiss Tropical and Public Health Institute, Allschwil, Switzerland. Hauptthemen laut MEDLINE: Soil, Helminthiasis, Anthelmintics. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Johnson & Johnson (New Brunswick, New Jersey, United States of America), Vector Borne and Neglected Tropical Disease Division, Ministry of Health, Uganda, Johnson and Johnson.
Abstract (Originalsprache)
Background Soil-transmitted helminth (STH) infections remain a public health problem in Uganda despite biannual national deworming campaigns implemented since the early 2000s. Recent surveys have indicated a heterogeneous STH infection prevalence, suggesting that the current blanket deworming strategy may no longer be cost-effective. This study identified infection predictors, estimated the geographic distribution of STH infection prevalence by species, and calculated deworming needs for school-age children (SAC). Methodology Bayesian geostatistical models were applied to STH survey data (2021–2023) for each species (i.e., Ascaris lumbricoides , hookworm, and Trichuris trichiura ). Climatic, environmental, and socioeconomic predictors were obtained from remote sensing sources, model-based databases, and demographic and health surveys. Prevalence was predicted on a 1 × 1 km 2 grid across Uganda, and district-level estimates were used to classify each district into treatment frequency categories and to determine its deworming tablet requirements. Principal findings The national prevalence of A. lumbricoides , T. trichiura, and hookworm was estimated at 5.0% (95% Bayesian credible interval [BCI]: 0.8–11.8%), 3.5% (0.7–9.3%), and 7.2% (5.7–11.1%), respectively. The overall prevalence of any STH infection was 14.3% (9.6–21.8%). High intra-district variation in prevalence was observed. Of 146 implementation units (136 districts and 10 cities), 49 require twice-year treatment, 34 once-yearly treatment, 61 every other year treatment, and 2 had a prevalence
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Swiss Tropical and Public Health Institute, Allschwil, Switzerland.
- University of Basel, Basel, Switzerland.
- Children Without Worms, The Task Force for Global Health, Decatur, Georgia, United States of America.
- Vector Borne and Neglected Tropical Diseases Division, Ministry of Health, Kampala, Uganda.
ORCID-Profile: Penelope Vounatsou
Förderung
- Johnson & Johnson (New Brunswick, New Jersey, United States of America)
- Vector Borne and Neglected Tropical Disease Division, Ministry of Health, Uganda
- Johnson and Johnson
Zitieren
APA
Nyawanda, B. O., Sullivan, K. M., Tinkitina, B., Beinamaryo, P., Nabatte, B., Kyarisiima, H., Mubangizi, A., Emerson, P. M., Utzinger, J., & Vounatsou, P. (2025). Geostatistical analysis to guide treatment decisions for soil-transmitted helminthiasis control in Uganda. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0013467
Vancouver
Nyawanda BO, Sullivan KM, Tinkitina B, Beinamaryo P, Nabatte B, Kyarisiima H, et al. Geostatistical analysis to guide treatment decisions for soil-transmitted helminthiasis control in Uganda. PLOS Neglected Tropical Diseases. 2025. doi:10.1371/journal.pntd.0013467
BibTeX
@article{Nyawanda2025,
author = {Nyawanda, Bryan O and Sullivan, Kristin M and Tinkitina, Benjamin and Beinamaryo, Prudence and Nabatte, Betty and Kyarisiima, Hilda and Mubangizi, Alfred and Emerson, Paul M and Utzinger, Jürg and Vounatsou, Penelope},
title = {Geostatistical analysis to guide treatment decisions for soil-transmitted helminthiasis control in Uganda},
journal = {PLOS Neglected Tropical Diseases},
year = {2025},
doi = {10.1371/journal.pntd.0013467}
}
EUVIMED